Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Transitional Cell 13Urinary Bladder Neoplasms 12Ureteral Neoplasms 4Neoplasm Metastasis 3Urologic Neoplasms 2Urogenital Neoplasms 2Carcinoma, Renal Cell 2Urologic Diseases 1Urogenital Diseases 1Urinary Bladder Diseases 1Urachal adenocarcinoma 1Salivary Gland Neoplasms 1Renal Pelvis and Ureter Urothelial Carcinoma 1Peripheral Nervous System Diseases 1Penile Squamous Cell Carcinoma (PSCC) 1Penile Neoplasms 1Neoplasms by Site 1Neoplasms 1Muscle-invasive Bladder Cancer 1Muscle Invasive Bladder Urothelial Carcinoma 1Metastatic Urothelial Cancer 1Melanoma 1Male Urogenital Diseases 1Female Urogenital Diseases 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma, Adenoid Cystic 1Breast Neoplasms 1Advanced Bladder Cancer 1

Interventions

Nivolumab 28pembrolizumab 24cabozantinib 23Ipilimumab 18Specimen Handling 13Magnetic Resonance Spectroscopy 13Axitinib 12lenvatinib 10Radiosurgery 9belzutifan 8atezolizumab 6CTLA-4 Antigen 6Biopsy 6cemiplimab 5Radiotherapy 5Bevacizumab 5toripalimab 4Everolimus 4Blood Specimen Collection 4avelumab 3aldesleukin 3X-Rays 3Sunitinib 3Standard of Care 3Paclitaxel 3zimberelimab 2trastuzumab deruxtecan 2tivozanib 2spartalizumab 2pazopanib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Renal Cell × enfortumab vedotin × Clear all
NCT06724159 2026-02-17

SOGUG-PRINCIS

Spanish Oncology Genito-Urinary Group

Recruiting
500 enrolled
Genitourinary

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urogenital Neoplasms

NCT06302569 2025-09-09

REPRINT

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Recruiting
23 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡